West Pharmaceutical Services (WST) Financial Forecast Calculator
Interactive 5-year forecast and DCF for West Pharmaceutical Services. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from West Pharmaceutical Services’s most recent SEC filings.
Assumptions
Need this as an Excel model?
Keep iterating on the West Pharmaceutical Services forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.
Other Healthcare forecasts
Run the same calculator on a peer.
Frequently asked
What does West Pharmaceutical Services (WST) do?+
West Pharmaceutical Services is a leading global manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The company designs and produces elastomer-based components, seals, and auto-injector systems essential for the safe and effective delivery of various pharmaceutical products.
What are the primary revenue drivers for West Pharmaceutical Services?+
West Pharmaceutical Services' revenue is primarily driven by its exposure to high-value product (HVP) components, the growth in biologics, and the adoption of GLP-1 auto-injectors. The business benefits from highly recurring revenue because its components are typically specified directly into customer regulatory filings, creating significant switching costs.
What is the typical capital expenditure as a percentage of revenue for West Pharmaceutical Services?+
Capital expenditure for West Pharmaceutical Services typically ranges from 8% to 12% of revenue, reflecting its asset-heavy business model due to precision manufacturing requirements. For example, in FY2025, capex was approximately 9.3% of revenue, with a significant portion allocated to expanding HVP manufacturing capacity.
What are the key profitability assumptions used in the financial model for West Pharmaceutical Services?+
The financial model for West Pharmaceutical Services assumes a Cost of Goods Sold (COGS) as a percentage of revenue at approximately 62.43%. Additionally, Selling, General, and Administrative (SGA) expenses are modeled at about 12.93% of revenue, contributing to the company's overall profitability profile.
What is the forecast horizon for the West Pharmaceutical Services financial model used for valuation?+
The financial model for West Pharmaceutical Services provides a comprehensive equity valuation and scenario analysis based on a forecast horizon from fiscal year 2026 through fiscal year 2030. This allows for a detailed assessment of the company's intrinsic value over a multi-year period.
Is there a downloadable financial model available for West Pharmaceutical Services (WST)?+
Yes, a downloadable Excel financial model is available for West Pharmaceutical Services (WST). This general corporate model offers a framework for equity valuation and scenario analysis, incorporating key assumptions about the company's financials and business drivers.
Have more financial modelling questions? Contact us
